Back to Cardiology
Cardiologyv2023Evidence-Based

Direct-Acting Oral Anticoagulants (DOAC) Score

Predicts bleeding risk in patients with atrial fibrillation on direct-acting oral anticoagulants

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
doac score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Direct-Acting Oral Anticoagulants (DOAC) Score is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within cardiology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

DOAC Score = Age points + Creatinine clearance points + Sum of risk factors (underweight, stroke/TIA/embolism history, diabetes, hypertension, antiplatelet use, NSAID use, bleeding history, liver disease). Maximum score is capped at 10 points.

Clinical Pearls & Practice Notes

  • Developed specifically for patients on direct oral anticoagulants (DOACs)
  • Superior performance compared to HAS-BLED score in DOAC-treated patients
  • Each additional point associated with 48.7% increase in major bleeding risk
  • Validated in multiple international cohorts including RE-LY, GARFIELD-AF, COMBINE-AF, and RAMQ
  • Should be used to guide clinical decision-making regarding anticoagulation therapy
  • Consider bleeding risk reduction strategies for moderate to very high risk patients

Evidence & Literature Citations

  1. Aggarwal A, Wang TY, Rumsfeld JS, et al. Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants. Circulation. 2023 Nov 7;148(19):1482-1492. doi: 10.1161/CIRCULATIONAHA.123.064556.
  2. Costa OS, Beyer-Westendorf J, Ashton V, et al. Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry. Thromb Res. 2024 Aug;240:109063. doi: 10.1016/j.thromres.2024.109063.

Score Interpretation Ranges

Very Low0 – 3 pts

Very low bleeding risk

Low4 – 5 pts

Low bleeding risk

Moderate6 – 7 pts

Moderate bleeding risk

High8 – 9 pts

High bleeding risk

Very High10 – 10 pts

Very high bleeding risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.